Market Tracker

05/27 1:45pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

10.35
BATS BZX Real-Time Price
As of 12:07pm ET
 +0.86 / +9.06%
Today’s Change
6.91
Today|||52-Week Range
14.50
+11.17%
Year-to-Date
3 Biotech Stocks to Buy in May
May 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close9.49
Today’s open9.90
Day’s range9.89 - 10.48
Volume45,505
Average volume (3 months)550,362
Market cap$409.5M
Dividend yield--
Data as of 12:07pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)-20.00%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...+0.84+6.19%
ACRSAclaris Therapeutics...+0.05+0.25%
TGTXTG Therapeutics Inc+0.39+5.40%
COCPCocrystal Pharma Inc-0.01-2.29%
Data as of 11:52am ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts